Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Bill 118 s 5349, also known as the "Medicare Breakthrough Devices Coverage Act," aims to make changes to title XVIII of the Social Security Act in order to ensure that breakthrough medical devices are promptly covered under the Medicare program.

The bill seeks to streamline the process for Medicare coverage of breakthrough devices, which are innovative medical technologies that have the potential to significantly improve patient outcomes. By ensuring prompt coverage of these devices, the bill aims to ensure that Medicare beneficiaries have timely access to cutting-edge medical treatments.

In addition to addressing coverage issues, the bill also includes provisions aimed at improving transparency and accountability in the Medicare coverage process for breakthrough devices. This includes requirements for the Centers for Medicare & Medicaid Services (CMS) to provide clear guidance on the coverage process and to establish a public database of breakthrough devices that have been approved for coverage. Overall, the Medicare Breakthrough Devices Coverage Act is designed to ensure that Medicare beneficiaries have access to the latest medical technologies and treatments, while also promoting transparency and accountability in the coverage process.